For those those who know off top of head...

SA article by Terry Chrisomalis “GlaxoSmithKline Makes A Bold Statement With Latest HIV Data $GSK” posted today talks about phase 3 study for once every two month injectable. That is the same once a month injectable that has drawbacks including nausea, lack of energy, kidney failure, painful, need to go to professional for injection. Right?

And resistance, right?

If so, Leronlimab is the way to go. Feel good with energy and easy to administer. My gut feeling is the HIV community is going to want the self injectable.